Brief: Lee's Pharmaceutical Holdings Says Qtrly Revenue Of HK$368.3 Mln
25/11/2021 10:13
Nov 25 (Reuters) - Lee's Pharmaceutical Holdings Ltd
0950.HK :
* QTRLY REVENUE HK$368.3 MILLION VERSUS HK$337.3 MILLION
* QTRLY PROFIT ATTRIBUTABLE HK$13.8 MILLION VERSUS HK$25
MILLION
Source text for Eikon: ID:nHKS3XVPZc
Further company coverage: 0950.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lee's Pharmaceutical Holdings
See all newsHong Kong's Lee's Pharmaceutical H1 profit jumps on higher-margin product sales
Brief: Lee's Pharmaceutical Expects H1 Net Profit Of HK$85 Million-HK$95 Million
Brief: Lee's Pharmaceutical Says Investigational New Drug Application For ADC Project ZK2401 Accepted By NMPA
Brief: Ashlins Pharmaceuticals And Lee's Pharm Announce Exclusive License And Supply Agreement Valued At Up To $31 Million
Brief: Lee's Pharmaceutical Says Entered Licensing Agreement With Ashlins Ocular Pharmaceuticals